Drug Discovery, Development, and Synthesis for Glioblastoma
A special issue of Pharmaceuticals (ISSN 1424-8247). This special issue belongs to the section "Pharmacology".
Deadline for manuscript submissions: 30 July 2025 | Viewed by 1342
Special Issue Editors
Interests: drug synthesis; anticancer; medicinal chemistry; organic synthesis
Interests: biomaterials; glioblastoma; platinum resistant ovarian cancer; bone tissue engineering
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Glioblastoma is the most common and lethal malignant primary brain tumor. Glioblastoma treatments remain difficult, and for now, no curative treatments are available.
The current initial treatment includes surgery, radiation therapy, medication therapy, or a combination of these therapies. However, the overall survival rate for glioblastoma remains quite low, with these tumors often leading to death within a year of diagnosis. Many factors, such as tumor heterogeneity, tumor location in a region, and rapid, aggressive tumor relapse, make the treatment more challenging. Finding more efficacious therapies is an urgent issue.
In recent years, significant progress has been made in identifying more effective anti-glioblastoma regimens. While overall mortality rates remain high, our improved understanding of the molecular mechanisms and genetic mutations has led to more promising therapeutic approaches. This progress has shed light on the future of glioblastoma treatment.
Pharmaceuticals invites you to share your expertise in the form of reviews and original articles on the challenges of pharmaceutical treatment for glioblastoma, particularly in drug discovery, development, and synthesis, including drug discovery from natural products, biomolecules, drug modification, small-molecule synthesis, combination therapies, and other pharmaceutical applications. The collection of manuscripts will be published as a Special Issue of the journal.
Dr. Shizue Mito
Dr. Sue Anne Chew
Prof. Dr. Mitsuhiro Arisawa
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- glioblastoma
- drug design
- drug synthesis
- anticancer
- natural products
- biomolecules
- combination therapy
- pharmaceuticals
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
